HANNAH SHERROD: Open Payments
NPI 1801400031 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 46 payments from 16 companies in 2025. Trend: 2023 $1,279 · 2024 $1,325 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 12 | $298 |
| Sumitomo Pharma America, Inc. | 6 | $140 |
| Dendreon Pharmaceuticals LLC | 3 | $121 |
| IMMUNITYBIO, INC. | 2 | $73 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Janssen Biotech, Inc. | 4 | $61 |
| Endo USA, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $34 |
Products named: JELMYTO, ZUSDURI, PROVENGE, GEMTESA, ANKTIVA, PLUVICTO, ORGOVYX, ERLEADA.
Industry payments across TN — which companies pay providers there.
